Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03826030 · ClinicalTrials.gov registry record · Phase 2
Transcranial Direct Current Stimulation for Post-stroke Motor Recovery
A Phase 2 study of Stroke, Ischemic and Motor Activity, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 129
- Enrollment target
- 14
- Study locations
NCT03826030 is a Phase 2 study of Stroke, Ischemic and Motor Activity that has completed, run by Duke University. The registered enrollment target is 129 participants, below the 286-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (55% lower). The trial reports 14 study locations across 12 states.
The verdict
NCT03826030, a Phase 2 study of Stroke, Ischemic and Motor Activity, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 129 participants
- Enrollment target
- 14
- Study locations
Study Summary
This research study is to find out if brain stimulation at different dosage level combined with an efficacy-proven rehabilitation therapy can improve arm function. The stimulation technique is called transcranial direct current stimulation (tDCS). The treatment uses direct currents to stimulate specific parts of the brain affected by stroke. The adjunctive rehabilitation therapy is called "modified Constraint-Induced Movement Therapy" (mCIMT). During this therapy the subject will wear a mitt on the hand of the arm that was not affected by a stroke and force to use the weak arm. The study will test 3 different doses of brain stimulation in combination with mCIMT to find out the most promising one.
Conditions Studied
Interventions
- DEVICE Sham
- DEVICE Low dose tDCS
- DEVICE High dose tDCS
- BEHAVIORAL mCIMT
Study Locations (14)
Ohio
- University of Cincinnati Medical Center - Cincinnati
- Cleveland VA Medical Center - Cleveland
Pennsylvania
- Moss Rehabilitation Research Institute - Elkins Park
- University of Pittsburgh Medical Center Presbyterian Hospital - Pittsburgh
Alabama
- University of Alabama at Birmingham Hospital - Birmingham
California
- Keck Hospital of USC - Los Angeles
District of Columbia
- MedStar National Rehabilitation Hospital - Washington D.C.
Georgia
- Emory Rehabilitation Hospital - Atlanta
Kentucky
- Cardinal Hill Rehabilitation Hospital - Lexington
Massachusetts
- Baystate Medical Center - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2024-09-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03826030
The ClinicalTrials.gov registry entry for NCT03826030 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 286-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (55% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Stroke, Ischemic appearing as the primary indexed condition, and to 4 interventions - of which Sham is the first listed.
NCT03826030 reports 14 study locations spanning 12 distinct geographic areas - top geographies include Ohio, Pennsylvania, Alabama.
Frequently Asked Questions
What is clinical trial NCT03826030 about?
NCT03826030 is a clinical study titled "Transcranial Direct Current Stimulation for Post-stroke Motor Recovery". This research study is to find out if brain stimulation at different dosage level combined with an efficacy-proven rehabilitation therapy can improve arm function. The stimulation technique is called transcranial direct current stimulation (tDCS). The treatment uses direct currents to stimulate spec...
What is the current status of trial NCT03826030?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 129 participants. The study started on 2019-09-01. Estimated completion is 2024-09-19.
What conditions does trial NCT03826030 study?
This clinical trial studies the following conditions: Stroke, Ischemic, Motor Activity, Upper Extremity Paralysis.
What interventions are being tested in trial NCT03826030?
The interventions under investigation include: Sham (DEVICE), Low dose tDCS (DEVICE), High dose tDCS (DEVICE), mCIMT (BEHAVIORAL).
Who is sponsoring clinical trial NCT03826030?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03826030 being conducted?
This trial has 14 study locations across Alabama, California, District of Columbia, Georgia, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Ischemic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Promoting Recovery After STroke With Amantadine
RECRUITING · Phase 2
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)
RECRUITING
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
-
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
RECRUITING
-
Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.